FDA Bolsters Warnings About Class of Antibiotics

TUESDAY, July 26, 2016 — The U.S. Food and Drug Administration announced Tuesday that it’s strengthening label warnings on a class of antibiotics called fluoroquinolones because the drugs can lead to disabling side effects, including long-term…
Source: Topamax